文献

J-GLOBAL ID：201902216289219295   整理番号：19S1356409

Combination therapy with zoledronic acid and cetuximab effectively suppresses growth of colorectal cancer cells regardless of KRAS status

著者 (8件)： Kato, Junko (Department of Surgical Oncology, Graduate School of Medicine, Gifu University) ,  Kanematsu, Masako (Department of Surgical Oncology, Graduate School of Medicine, Gifu University) ,  Gaowa, Siqin (Department of Surgical Oncology, Graduate School of Medicine, Gifu University) ,  Mori, Ryutaro (Department of Surgical Oncology, Graduate School of Medicine, Gifu University) ,  Tanahashi, Toshiyuki (Department of Surgical Oncology, Graduate School of Medicine, Gifu University) ,  Matsuhashi, Nobuhisa (Department of Surgical Oncology, Graduate School of Medicine, Gifu University) ,  Yoshida, Kazuhiro (Department of Surgical Oncology, Graduate School of Medicine, Gifu University) ,  Futamura, Manabu (Department of Breast and Molecular Oncology, Graduate School of Medicine, Gifu University)
資料名： International Journal of Cancer
巻： 138  号： 6  ページ： 1516-1527  発行年： 2016年 
JST資料番号： SCOPUS  ISSN： 0020-7136  CODEN： IJCNA 
発行国： アメリカ (USA)  言語： 英語 (EN)

タイトルに関連する用語 (3件)： Cetuximab ,  Cancer ,  KRAS